Cite
HARVARD Citation
Cecere, S. et al. (n.d.). D02Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial. Annals of oncology. p. vi33. [Online].